97 reports

Drugs For Respiratory Diseases P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A G E | ## ## P A

  • Respiratory Disease
  • World
  • Market Size
  • Novartis AG
  • Pfizer Inc.
  • 1.2 Types of PAP
  • 1.1 Pulmonary Alveolar Proteinosis (PAP)

A person with one normal gene and one gene for the disease will be a carrier for the disease and usually, do not show symptoms. ##. ## Types of PAP Congenital PAP: In congenital PAP, people are born with genetic mutations that interrupt the production of a normal surfactant.

  • Respiratory Disease
  • World
  • Forecast
  • Market Size
  • Mast Therapeutics, Inc.
  • 2.1 THERAPY AREA INTRODUCTION
  • RESPIRATORY DISORDERS THERAPEUTICS MARKET, GLOBAL, EPIDEMIOLOGY PATTERNS FOR

ALPHA-## ANTITRYPSIN DEFICIENCY SCREENING IS RECOMMENDED BY THE WORLD HEALTH ORGANIZATION (WHO) IN PATIENTS FROM AREAS WHERE THIS GENETIC DEFICIENCY IS HIGHLY PREVALENT.

  • Respiratory Disease
  • World
  • Market Size
  • Astellas Pharma Inc.
  • AstraZeneca PLC
  • THE PATHOGENESIS OF COPD
  • 5.2 RISK FACTORS AND COMORBIDITIES

AAT DEFICIENCY IS THE MOST WELL-KNOWN GENETIC FACTOR FOR COPD, AFFECTING BETWEEN ##% AND ##% OF COPD PATIENTS.

  • Respiratory Disease
  • Australia
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Sunovion Pharmaceuticals Inc.
  • BREAKTHROUGH IN COPD RESEARCH

Genetic factors: Alpha-## antitrypsin (AAT) deficiency, in rare cases, is also believed to play a role in developing the disease.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • Novartis AG
  • GLOBAL ASTHMA OXYGEN THERAPY EQUIPMENT
  • TH RAPY EQUIPMENT M RK T

GENETIC PREDISPOSITION AS WELL AS RAPIDLY GROWING AIR POLLUTION HAS BEEN TRIGGERING THE UPSURGE OF ACUTE ASTHMA.

  • Respiratory Disease
  • World
  • Inogen, Inc.
  • Invacare Corporation
  • Philips Respironics, Inc.

Note: ##.

  • Respiratory Disease
  • United States
  • World
  • Forecast
  • Adherium Limited

Global Allergic Rhinitis Drugs Market 2017-2027 ##.

  • Allergy Drug
  • Respiratory Disease
  • World
  • Forecast
  • Market Shares
  • MARKET OUTLINE

Genetic factors: Alpha-## antitrypsin deficiency is also believed to play a role in the development of COPD; but it is exquisite.

  • Respiratory Disease
  • AstraZeneca PLC
  • Boehringer Ingelheim GmbH
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • Increasing prevalence of allergic rhinitis and asthma coupled with high consumption of tobacco

You can easily book an appointment with one online.

  • Respiratory Disease
  • World
  • Allergy Therapeutics plc
  • Merck & Co., Inc.
  • Stallergenes SA
  • Identifying factors impacting market growth

In addition to genetic factors, lifestyle factors also influence the prevalence of allergic rhinitis.

  • Respiratory Disease
  • World
  • Forecast
  • GlaxoSmithKline plc
  • Sanofi S.A.
  • EMPHYSEMA GLOBAL MARKET REVENUE, BY REGION, (2014-2022) ($MN)
  • 5.4.2 EMPHYSEMA

BESIDES SMOKING, THE OTHER MAJOR KNOWN CAUSE OF EMPHYSEMA IS GENETIC RISK FACTOR ALPHA-## ANTITRYPSIN DEFICIENCY IN BLOOD WHICH RESULTS IN LUNG DETERIORATION BY WHITE BLOOD CELLS.

  • Respiratory Disease
  • World
  • Market Size
  • Medtronic, Inc.
  • ResMed Inc.

You can easily book an appointment with one online.

  • Respiratory Device
  • Respiratory Disease
  • World
  • Forecast
  • Teleflex Incorporated
  • Market drivers
  • INCREASED PREVALENCE OF ALLERGIC RHINITIS

You can easily book an appointment with one online.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Sanofi S.A.
  • Strength
  • Market drivers

Genetic factors are thought to play a significant role in disease management.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • Market challenges
  • Market drivers

You can easily book an appointment with one online.

  • Respiratory Disease
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Merck & Co., Inc.
  • Novartis AG
  • INTRODUCTION
  • LIST OF FIGURES

FIGURE ##. ## COPD: DISTRIBUTION OF DIRECT COST TO NHS, UK Abbreviations: GP- General practitioner; A& E: Accident and Emergency CYSTIC FIBROSIS IS ONE OF THE MOST COMMON GENETIC DISORDERS.

  • Respiratory Disease
  • North America
  • United States
  • AstraZeneca PLC
  • Novartis AG

THE DIAGNOSTICS BUSINESS INCLUDES BIO-REFERENCE LABORATORIES, THE NATION' S THIRD-LARGEST CLINICAL LABORATORY WITH A CORE GENETIC TESTING BUSINESS.

  • Respiratory Disease
  • Adherium Limited
  • Bluetooth SIG, Inc.
  • GlaxoSmithKline plc
  • Novartis AG

Cystic fibrosis (CF) is a type of genetic disorder that affects the body' s exocrine glands which secrete saliva, mucus, tears and sweats.

  • Respiratory Disease
  • World
  • Market Size
  • Astra Group
  • Becton Property Group

Allergic Rhinitis Drugs Market Forecast 2016-2026 ##.

  • Allergy Drug
  • OTC
  • Respiratory Disease
  • World
  • Market Shares
  • Asthma Therapeutics Market, Asia-Pacific, Market Size ($bn), 2016-2023
  • 6 Multi-Scenario Forecast

Research has highlighted numerous potential causes, the majority of which can be classed as either genetic or environmental.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • GlaxoSmithKline plc
  • Novartis AG
  • RISK FACTORS FOR COPD THAT HAVE A ROLE DURING DIFFERENT STAGES OF LIFE
  • RISK FACTORS FOR COPD THAT HAVE A ROLE DURING DIFFERENT STAGES OF LIFE

term=GLOW+##& rank=## [Accessed ## March 2016].

  • Respiratory Disease
  • European Union
  • Japan
  • North America
  • United States
  • 4.2 EPIDEMIOLOGY

Research has highlighted numerous potential causes, the majority of which can be classed as either genetic or environmental.

  • Respiratory Disease
  • World
  • Almirall, S.A.
  • Genentech, Inc.
  • Novartis AG
  • 1.4 TREATMENT OPTIONS FOR ASTHMA

The main cause of COPD is smoking, with scarcer causes including air pollution and genetic disorders.

  • Respiratory Disease
  • World
  • AstraZeneca PLC
  • Merck & Co., Inc.
  • Novartis AG
  • JAN 19, 2018: RESEARCHERS ANALYZE BIG DATA, AIM FOR LUNG DISEASE PRECISION TREATMENT IMPROVEMENT

Hyperlipidemia is one of the most common risk factors for atherosclerosis.

  • Asthma
  • Cardiovascular Disease
  • Healthcare
  • Respiratory Disease
  • United States
  • Comorbidities
  • RISK FACTORS AND COMORBIDITIES FOR COPD

AAT deficiency is the most well-known genetic factor for COPD, affecting between ##% and ##% of COPD patients.

  • Respiratory Disease
  • Australia
  • World
  • Forecast
  • Social Conditions
  • REFERENCES

A meta-analysis of Th## pathway genetic variants and risk for allergic rhinitis.

  • Respiratory Disease
  • East Asia
  • Northern Europe
  • South Korea
  • Western Europe
  • ASTRAZENECA: US REVENUE OF KEY ASTHMA DRUGS 2011-2014 ($ MILLIONS)
  • 17. Market Growth Drivers

Genetic factors are thought to play a significant role in disease management.

  • Respiratory Disease
  • United States
  • AstraZeneca PLC
  • F. Hoffmann-La Roche Ltd.
  • GlaxoSmithKline plc
  • CAUSE OF THE DISEASE
  • Clinical phenotypes of asthma using cluster analysis

Genetic heterogeneity of asthma phenotypes identified by a clustering approach.

  • Asthma
  • Chronic Disease
  • Pathology
  • Respiratory Disease

North America COPD & Asthma Devices Market (2016-2022) North America COPD & Asthma Devices Market Table of Contents Chapter ##.

  • Air Way Device
  • Asthma
  • Respiratory Device
  • Respiratory Disease
  • North America